Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

William Blair

Investor type Investment Bank
Founders James Vaughan

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 24
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 20
Rounds per year 0.28
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 10
Key employees 1

Areas of investment

  • Health Care
  • Biotechnology
  • Information Technology
  • Software
  • Manufacturing
Summary

William Blair is the famous Corporate Investor, which was founded in 1935. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Chicago.

The current fund was established by James Vaughan.

The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Inhibitex, Athersys, Xan3D Technologies. We can highlight the next thriving fund investment areas, such as Information Services, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the William Blair, startups are often financed by MPM Capital, Forward Ventures, Enterprise Partners. The meaningful sponsors for the fund in investment in the same round are Enterprise Partners, Reicon Capital, Optical Partners. In the next rounds fund is usually obtained by Forward Ventures, Enterprise Partners, BB Biotech Ventures.

The high activity for fund was in 2000. The real fund results show that this Corporate Investor is 15 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this William Blair works on 19 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2005. The average startup value when the investment from William Blair is 50-100 millions dollars. The fund is constantly included in less than 2 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of William Blair:
Typical Co-investors
William Blair is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after William Blair:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Banco Santander Madrid, Madrid, Spain
Bonit Capital Stockholm, Stockholm County, Sweden
Capital Impetus Group Central, Central Region, Singapore
Coffee Stain Studios Sweden, Vastra Gotaland, Västra Götaland County
Gefen Biomed Investments Ashkelon, HaDarom, Israel
Gestion AD -
Kohlberg Kravis Roberts Japan Chiyoda, Japan
Nanhai Zhiku China, Guangdong, Tianjin
Suneight PS1 Investment -
Viroad Biotechnology China, Hebei, Shijiazhuang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Halo Investing

Finance
Financial Services
FinTech
$100M12 Oct 2021 Chicago, Illinois, United States

Athersys

Biotechnology
Health Care
Pharmaceutical
$9M23 Mar 2012 Cleveland, Ohio, United States

Athersys

Biotechnology
Health Care
Pharmaceutical
$13M28 Jan 2011 Cleveland, Ohio, United States

Inuvo

Advertising
Local
Local Business
Search Engine
$4M19 Jan 2010 Little Rock, Arkansas, United States

TargeGen

Biopharma
Biotechnology
Health Care
$30M26 Sep 2005 San Diego, California, United States

HouseValues

Commercial Real Estate
Innovation Management
Real Estate
$14M21 May 2004 Washington, United States

Xan3D Technologies

3D Technology
Information Technology
Manufacturing
Semiconductor
$15M20 May 2004 New Hampshire, United States

NuVasive

Biotechnology
Health Care
Medical Device
$9M13 May 2004 San Diego, California, United States

TargeGen

Biopharma
Biotechnology
Health Care
$30M15 Jan 2004 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent William Blair?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: